BlackRock, Inc.

Position in BMY — Bristol Myers Squibb Co

CIK 2012383 New York, NY

Position in BMY

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$10,412,567,149

+$874,604,759 QoQ

Shares Held

171,682,888

-2.9% QoQ

Ownership

8.41%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 88.84933592711543.ToString("F0")% Shared 0.ToString("F0")% None 11.150664072884561.ToString("F0")%

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $235,197,977,777 across 20 Drug Manufacturers - General names. BMY ranks #8 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	66,380,842	$61,055,107,035
2	JNJ	Johnson & Johnson	213,385,546	$52,159,962,852
3	ABBV	AbbVie Inc.	150,698,125	$32,775,335,197
4	MRK	Merck & Co., Inc.	225,830,330	$27,165,130,383
5	GILD	Gilead Sciences, Inc.	119,010,973	$16,586,559,291
6	AMGN	Amgen Inc	47,100,472	$16,572,301,062
7	PFE	Pfizer Inc	498,257,550	$13,991,071,992
8	BMY	Bristol Myers Squibb Co This page	171,682,888	$10,412,567,149

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,412,567,149	171,682,888	-2.9%	Shares	Sole	2026-05-13
2025-12-31	$9,537,962,390	176,825,406	+0.7%	Shares	Sole	2026-02-12
2025-09-30	$7,915,733,931	175,515,165	+1.9%	Shares	Sole	2025-11-12
2025-06-30	$7,972,356,760	172,226,329	+6.7%	Shares	Sole	2025-08-12
2025-03-31	$9,841,733,921	161,366,354	+2.4%	Shares	Sole	2025-05-02
2024-12-31	$8,914,206,094	157,606,190	-1.3%	Shares	Sole	2025-02-07
2024-09-30	$8,260,408,699	159,652,275	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.